Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Hematology-Oncology Associates of the Treasure Coast, Port Saint Lucie, Florida Carolina BioOncology, Huntersville, North Carolina Greenville Hospital System University Medical Center (ITOR), Greenville, South Carolina UT Southwestern Medical Center, Dallas, Texas China
Hangzhou First People's Hospital, Hangzhou, Zhejiang Taiwan
Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City National Taiwan University Hospital, Taipei Taipei Veterans General Hospital, Taipei